Clinical Applications & Imaging Considerations of Gadopiclenol Injection
Lawrence N. Tanenbaum, MD, FACR | Applied Radiology
Accredited by The Association for Medical Imaging Management (AHRA) for 1.0 Category A ARRT and CRA continuing education credits.
In September 2022, Gadopiclenol injection, which is both macrocyclic (stable) and has high relaxivity properties received FDA marketing approval and may provide dosing options that can decrease gadolinium exposure, particularly in vulnerable patients.
In this accredited webinar, the assessment of Gadopiclenol injection in neuro, body, and pediatric MR imaging will be presented by a panel of MR imaging experts and will include commentary from Lawrence N. Tanenbaum, MD. To encourage audience participation, a live Q & A session will follow the discussion.